Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brullo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|June 10, 2011
ATP-competitive inhibitors of mTOR: an updateS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|November 5, 2011
SRC kinase inhibitors: an update on patented compoundsS Schenone, C Brullo, F Musumeci, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
A1 receptors ligands: past, present and future trendsS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|February 11, 2015
Hck inhibitors as potential therapeutic agents in cancer and HIV infectionF Musumeci, S Schenone, C Brullo, et al.
Current Medicinal Chemistry|June 10, 2011
Fyn kinase in brain diseases and cancer: the search for inhibitorsS Schenone, C Brullo, F Musumeci, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2007
2-Amino/azido/hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological evaluationO Bruno, C Brullo, F Bondavalli, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activityO Bruno, C Brullo, A Ranise, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylationS Schenone, O Bruno, A Ranise, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|June 10, 2011
ATP-competitive inhibitors of mTOR: an updateS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|November 5, 2011
SRC kinase inhibitors: an update on patented compoundsS Schenone, C Brullo, F Musumeci, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
A1 receptors ligands: past, present and future trendsS Schenone, C Brullo, F Musumeci, et al.
Current Medicinal Chemistry|February 11, 2015
Hck inhibitors as potential therapeutic agents in cancer and HIV infectionF Musumeci, S Schenone, C Brullo, et al.
Current Medicinal Chemistry|June 10, 2011
Fyn kinase in brain diseases and cancer: the search for inhibitorsS Schenone, C Brullo, F Musumeci, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2007
2-Amino/azido/hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological evaluationO Bruno, C Brullo, F Bondavalli, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activityO Bruno, C Brullo, A Ranise, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylationS Schenone, O Bruno, A Ranise, et al.
Pageof 2